These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37729419)

  • 21. BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy.
    Zimmermann T; Thomas L; Baader-Pagler T; Haebel P; Simon E; Reindl W; Bajrami B; Rist W; Uphues I; Drucker DJ; Klein H; Santhanam R; Hamprecht D; Neubauer H; Augustin R
    Mol Metab; 2022 Dec; 66():101633. PubMed ID: 36356832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.
    Zhang Y; Rahematpura S; Ragnini KH; Moreno A; Stecyk KS; Kahng MW; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
    Neuropharmacology; 2021 Jul; 192():108599. PubMed ID: 33965397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.
    McKay NJ; Kanoski SE; Hayes MR; Daniels D
    Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1755-64. PubMed ID: 21975647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraventricular Thalamic Control of Food Intake and Reward: Role of Glucagon-Like Peptide-1 Receptor Signaling.
    Ong ZY; Liu JJ; Pang ZP; Grill HJ
    Neuropsychopharmacology; 2017 Nov; 42(12):2387-2397. PubMed ID: 28811669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation.
    Costa A; Ai M; Nunn N; Culotta I; Hunter J; Boudjadja MB; Valencia-Torres L; Aviello G; Hodson DJ; Snider BM; Coskun T; Emmerson PJ; Luckman SM; D'Agostino G
    Mol Metab; 2022 Jan; 55():101407. PubMed ID: 34844019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
    Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
    J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of lateral septum glucagon-like peptide 1 receptors in food intake.
    Terrill SJ; Jackson CM; Greene HE; Lilly N; Maske CB; Vallejo S; Williams DL
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R124-32. PubMed ID: 27194565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y
    Yuan Y; Yan Z; Lao Q; Jiang N; Wu S; Lu Q; Han J; Zhao S
    Eur J Med Chem; 2023 Feb; 247():115036. PubMed ID: 36571995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy.
    Roth E; Benoit S; Quentin B; Lam B; Will S; Ma M; Heeley N; Darwish T; Shrestha Y; Gribble F; Reimann F; Pshenichnaya I; Yeo G; Baker DJ; Trevaskis JL; Blouet C
    Mol Metab; 2021 Jan; 43():101118. PubMed ID: 33221554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner.
    Zhao S; Kanoski SE; Yan J; Grill HJ; Hayes MR
    Int J Obes (Lond); 2012 Dec; 36(12):1522-8. PubMed ID: 22249232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models.
    Borner T; Geisler CE; Fortin SM; Cosgrove R; Alsina-Fernandez J; Dogra M; Doebley S; Sanchez-Navarro MJ; Leon RM; Gaisinsky J; White A; Bamezai A; Ghidewon MY; Grill HJ; Crist RC; Reiner BC; Ai M; Samms RJ; De Jonghe BC; Hayes MR
    Diabetes; 2021 Nov; 70(11):2545-2553. PubMed ID: 34380697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
    Chelikani PK; Haver AC; Reidelberger RD
    Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain.
    Heppner KM; Kirigiti M; Secher A; Paulsen SJ; Buckingham R; Pyke C; Knudsen LB; Vrang N; Grove KL
    Endocrinology; 2015 Jan; 156(1):255-67. PubMed ID: 25380238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypophagia induced by hindbrain serotonin is mediated through central GLP-1 signaling and involves 5-HT2C and 5-HT3 receptor activation.
    Leon RM; Borner T; Reiner DJ; Stein LM; Lhamo R; De Jonghe BC; Hayes MR
    Neuropsychopharmacology; 2019 Sep; 44(10):1742-1751. PubMed ID: 30959513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt.
    Rupprecht LE; Mietlicki-Baase EG; Zimmer DJ; McGrath LE; Olivos DR; Hayes MR
    Am J Physiol Endocrinol Metab; 2013 Sep; 305(6):E751-9. PubMed ID: 23900416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLP-1R agonism enhances adjustable gastric banding in diet-induced obese rats.
    Habegger KM; Kirchner H; Yi CX; Heppner KM; Sweeney D; Ottaway N; Holland J; Amburgy S; Raver C; Krishna R; Müller TD; Perez-Tilve D; Pfluger PT; Obici S; DiMarchi RD; D'Alessio DA; Seeley RJ; Tschöp MH
    Diabetes; 2013 Sep; 62(9):3261-7. PubMed ID: 23775764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GLP-1 and weight loss: unraveling the diverse neural circuitry.
    Kanoski SE; Hayes MR; Skibicka KP
    Am J Physiol Regul Integr Comp Physiol; 2016 May; 310(10):R885-95. PubMed ID: 27030669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
    Steinert RE; Schirra J; Meyer-Gerspach AC; Kienle P; Fischer H; Schulte F; Goeke B; Beglinger C
    Am J Clin Nutr; 2014 Aug; 100(2):514-23. PubMed ID: 24965303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: neuroanatomical, electrophysiological, and behavioral evidence.
    Richard JE; Farkas I; Anesten F; Anderberg RH; Dickson SL; Gribble FM; Reimann F; Jansson JO; Liposits Z; Skibicka KP
    Endocrinology; 2014 Nov; 155(11):4356-67. PubMed ID: 25116706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.